Literature DB >> 15328134

Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae.

Paul F Riska1, Andrei Kutlin, Patrick Ajiboye, Arnold Cua, Patricia M Roblin, Margaret R Hammerschlag.   

Abstract

Three clinical Chlamydia pneumoniae isolates for which the MIC of azithromycin increased after treatment were investigated for genetic evidence of macrolide resistance. Attempts to induce antibiotic resistance in vitro were made. No genetic mechanism was identified for the phenotypic change in these C. pneumoniae isolates. No macrolide resistance was obtained in vitro.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15328134      PMCID： PMC514725          DOI： 10.1128/AAC.48.9.3586-3590.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.

Authors:  R B Jones; B Van der Pol; D H Martin; M K Shepard
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

3.  Increased kasugamycin sensitivity in Escherichia coli caused by the presence of an inducible erythromycin resistance (erm) gene of Streptococcus pyogenes.

Authors:  A N Suvorov; B van Gemen; P H van Knippenberg
Journal:  Mol Gen Genet       Date:  1988-12

4.  Binding of erythromycin to the 50S ribosomal subunit is affected by alterations in the 30S ribosomal subunit.

Authors:  L Saltzman; D Apirion
Journal:  Mol Gen Genet       Date:  1976-02-02

5.  Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex.

Authors:  K A Nash; C B Inderlied
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

6.  Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.

Authors:  P M Roblin; G Montalban; M R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

Review 7.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Microbiol Rev       Date:  1994-12

8.  Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.

Authors:  R J Suchland; W M Geisler; Walter E Stamm
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

9.  Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.

Authors:  K A Nash; C B Inderlied
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

10.  Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.

Authors:  S Block; J Hedrick; M R Hammerschlag; G H Cassell; J C Craft
Journal:  Pediatr Infect Dis J       Date:  1995-06       Impact factor: 2.129
View more
  3 in total

Review 1.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

2.  Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Direct assessment of possible mutations in the 23S rRNA gene encoding macrolide resistance in Chlamydia trachomatis.

Authors:  J M van Niekerk; I H M van Loo; M Lucchesi; S A Morré; C J P A Hoebe; N H T M Dukers-Muijrers; P F G Wolffs
Journal:  PLoS One       Date:  2022-05-10       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.